key: cord-0918291-emwu5g5f
authors: Konopka, Kristine E.; Wilson, Allecia; Myers, Jeffrey L.
title: Postmortem Lung Findings in an Asthmatic with Coronavirus Disease 2019 (COVID-19)
date: 2020-04-28
journal: Chest
DOI: 10.1016/j.chest.2020.04.032
sha: cc31ceffd9e9144741030a00dff90c1a5952243b
doc_id: 918291
cord_uid: emwu5g5f

Abstract Asthma is increasingly recognized as an underlying risk factor for severe respiratory disease in coronavirus disease 2019 (COVID-19) patients, particularly in the United States. Here, we report the postmortem lung findings from a 37-year-old asthmatic man, who met the clinical criteria for severe acute respiratory distress syndrome and died of COVID-19 less than two weeks after presentation to the hospital. His lungs showed mucus plugging and other histologic changes attributable to asthma, as well as early diffuse alveolar damage (DAD) and a fibrinous pneumonia. The presence of DAD is similar to descriptions of autopsy lung findings from patients with severe acute respiratory syndrome coronavirus (SARS) and Middle East respiratory syndrome coronavirus (MERS), and the absence of a neutrophil-rich acute bronchopneumonia differs from the histologic changes typical of influenza. The relative contribution of mucus plugging to his hypoxemia is unknown.

Novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of the respiratory illness coronavirus disease 2019 , emerged in Wuhan, China, in late 2019. 1 Since then, it has rapidly spread to cause a worldwide health crisis. While most patients experience mild symptoms, 5% of patients suffer catastrophic respiratory failure and of those, approximately half die of disease. 2, 3 In Chinese populations, diabetes, hypertension, and cardiovascular disease are the most commonly reported comorbidities and are associated with worse survival. [4] [5] [6] [7] Early data from the Centers for Disease Control and Prevention showed similar findings, and also identified underlying lung disease as a risk factor in the United States (US). Nearly 10% of US COVID-19 patients have chronic lung disease, including asthma, as a risk factor. 8 In contrast, only 2% of cases in Chinese studies had chronic lung disease. [4] [5] [6] [7] Here, we document the first case report of postmortem lung findings in an asthmatic patient who died of COVID-19.

A 37-year-old man presented with one-day history of fever, non-productive cough, and myalgias, and was admitted for medical management of presumptive COVID-19. He later tested positive for SARS-CoV-2. His past medical history was most significant for asthma, managed with ipratropium bromide and albuterol inhaler, and type II diabetes on sitagliptin. On admission, computed tomography of the chest showed multifocal groundglass opacities. Treatment included hydroxychloroquine, empiric piperacillin/tazobactam and vancomycin, and corticosteroids. He suffered worsening hypoxemia, necessitating intubation and mechanical ventilation on hospital day (HD) 4, and met the Berlin criteria for severe acute respiratory distress syndrome (ARDS). 9 On HD 9, he suffered sudden decompensation in oxygenation followed by cardiogenic collapse, prompting transition to venous-arterial extracorporeal membrane oxygenation. Continuous renal replacement therapy was also initiated, but his severe lactic acidosis was unrelenting. Care was withdrawn on HD 9 and an autopsy was requested.

Upon gross examination, the lungs were heavy with mucus plugging of the conducting airways and consolidation of the lung parenchyma ( Figure 1 ). Despite the presence of mucus plugs, there was no evidence of hyperinflation/air-trapping, the anticipated finding in patients who die of status asthmaticus. 10 Histologic sections of the proximal airways corroborated the presence of paucicellular mucus plugs, but without tissue eosinophilia. Goblet cell metaplasia, mucus gland hyperplasia, and thickening of subepithelial basement membranes in cartilaginous and non-cartilaginous airways attested to the patient's history of asthma. The distal alveolated lung tissue showed diffuse alveolar damage (DAD), characterized by patchy, mild interstitial thickening by edema, focal pneumocyte hyperplasia, and scattered hyaline membranes, the histologic hallmark of DAD ( Figure 2 ). Rare fibrin thrombi were also identified within small vessels and a small muscular pulmonary artery consistent with endothelial injury. This was accompanied by a mild patchy fibrinous airspace exudate in which mononuclear inflammatory cells predominated with scattered neutrophils (Figure 3 ). While the inflammatory infiltrate was limited to distal airspaces without involvement of bronchi or bronchioles, this finding was morphologically similar to previous descriptions of COVID-19 pneumonia and may represent early bronchopneumonia. [11] [12] [13] Discussion DAD with a patchy fibrinous airspace exudate is the predominant finding in COVID-19associated ARDS. The findings are histologically typical, including epithelial necrosis targeting the distal pulmonary acinus, endothelial injury with associated fibrin thrombi in small vessels, hyperplasia of reparative type 2 pneumocytes that lack viral inclusions, and hyaline membranes. 14 Ours is among the earliest descriptions of pulmonary histologic changes in patients who die within weeks of symptom onset. Two previous reports also described DAD in COVID-19 patients with premortem diagnoses of ARDS. 12, 13 DAD was also a consistent autopsy finding in patients from the earlier severe acute respiratory syndrome (SARS) and

Middle East respiratory syndrome (MERS) coronavirus outbreaks. [15] [16] [17] In some SARS patients as in ours, a patchy, paucicellular fibrinous airspace pneumonia resembling acute fibrinous and organizing pneumonia was also reported. 18 DAD is also a common finding in patients infected with influenza viruses, including influenza A/H1N1, in which it is often accompanied by a combination of hemorrhage, acute bronchopneumonia in which neutrophils predominate, macroscopic thrombosis affecting peripheral pulmonary vessels, and hemophagocytosis. 19, 20 We identified none of these features in our patient, suggesting that the pathogenesis of COVID lung disease is different from these genetically distinct respiratory viruses.

Mucus plugs were a conspicuous feature in our patient and likely attributable to his asthma history rather than a direct effect of viral infection. It is unclear the extent to which this finding contributed to his respiratory failure, although it is conceivable that airflow limitation due to mucus plugging compounds the hypoxemia characteristic of DAD in COVID-19 patients with underlying asthma. 

A novel coronavirus from patients with pneumonia in China

Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese center for disease control and prevention

Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China

Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study

Clinical features of 85 fatal cases of COVID-19 from Wuhan: a retrospective observational study

Clinical characteristics of coronavirus disease 2019 in China

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet

Preliminary estimates of the prevalence of selected health conditions among patients with coronavirus disease 2019 -United States

Acute respiratory distress syndrome: the Berlin Definition

The pathology of asthma, with special reference to changes in the bronchial mucosa

Pulmonary pathology of early-phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer

Pathological findings of COVID-19 associated with acute respiratory distress syndrome

Histopathologic changes and SARS-CoV-2 immunostaining in the lung of a patient with COVID-19

Diffuse alveolar damage -the role of oxygen, shock, and related factors. A review

Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore

Clinicopathologic, immunohistochemical, and ultrastructural findings of a fatal case of Middle East respiratory syndrome coronavirus infection in the United Arab Emirates

Histopathology of Middle East respiratory syndrome coronavirus (MERS-CoV) infection -clinicopathological and ultrastructural study

Pulmonary pathology of severe acute respiratory syndrome in Toronto

Autopsy findings in eight patients with fatal H1N1 influenza

Postmortem findings in eight cases of influenza A/H1N1